As a result of participating in this activity, learners will be better able/better-able to:
Pain management domains and core competencies
4. Clinical conditions: How does context influence pain management?
Neurovations Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Neurovations Education designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Presenter: Roger Fillingim discloses the following financial relationships within the past 24 months: Consulting: UCB
No other person with control of, or responsibility for, the planning, delivery, or evaluation of accredited continuing education has, or has had within the past 24 months, financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships have been mitigated. Materials were reviewed in advance of the activity by person(s) that do not have conflicts of interest related to the content. In some cases, content may have been modified as part of the review and mitigation process. All clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines).
As a result of participating in this activity, learners will be better able to:
What is pain? Multidimensional nature of pain:
How is pain safely and effectively treated?
Neurovations Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Neurovations Education designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Presenter: Marom Bikson discloses the following financial relationships within the past 24 months: Stock: Soterix Medical; Grants, assigned inventions, and/or serves Scientific Advisory Board (Consulting): SafeToddles, Boston Scientific, GlaxoSmithKline, Biovisics, Mecta, Lumenis, Halo Neuroscience, Google-X, i-Lumen, Humm, Allergan (Abbvie), Apple
No other person with control of, or responsibility for, the planning, delivery, or evaluation of accredited continuing education has, or has had within the past 24 months, financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships have been mitigated. Materials were reviewed in advance of the activity by person(s) that do not have conflicts of interest related to the content. In some cases, content may have been modified as part of the review and mitigation process. All clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines).
1.Peterchev, AV, Wagner, TA, Miranda, PC, Nitsche, MA, Paulus, W, Lisanby, SH, Pascual-Leone, A, Bikson, M (2012). Fundamentals of transcranial electric and magnetic stimulation dose: Definition, selection, and reporting practices. Brain Stim, 5(4), 435-453
2.Melzack, R, Wall, PD (1965) Pain mechanisms: a new theory. Science;150(3699):971-9.
3.Sharma, M, Bhaskar, V, Yang, L, FallahRad, M, Gebodh, N, Zhang, T, Esteller, R, Martin, J, Bikson, M. (2023). Novel Evoked Synaptic Activity Potentials (ESAPs) Elicited by Spinal Cord Stimulation. eNeuro, 10(5)